U.S. Judge Orders Watson Executive to Comply With FTC Subpoena

Dec. 3 (Bloomberg) -- A Watson Pharmaceuticals Inc. executive has been ordered by a federal judge to comply with a U.S. Federal Trade Commission subpoena in a patent case involving Cephalon Inc.’s sleep-disorder drug Provigil.

Paul Bisaro, president and chief executive officer of Corona, California-based Watson, a generic-drug maker, “has failed to demonstrate” that the subpoena “would be burdensome at all, let alone unduly so,” U.S. District Judge Colleen Kollar-Kotelly wrote in her opinion.

Top Government stories: {TOP GOV <GO>}

To contact the reporter on this story: Jeff Bliss in Washington jbliss@bloomberg.net

To contact the editor responsible for this story: Mark Silva in Washington at msilva34@bloomberg.net